The status of drug wastage in the pediatric emergency department of a tertiary hospital

Background: The aim of this study was to evaluate surplus drugs left over from medications used via the intravenous and intramuscular routes in a pediatric emergency unit of a tertiary hospital in Turkey and to determine the financial burden imposed by drug wastage. Materials and Methods: The study...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ibrahim Hakan Bucak, Habip Almis, Cagla Nur Dogan, Mehmet Turgut
Formato:	article
Lenguaje:	EN
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2020
Materias:	cost drug formulations pediatric emergency department wastage Medicine R
Acceso en línea:	https://doaj.org/article/2fc9640b12e04f708de14928f2e3f468
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2fc9640b12e04f708de14928f2e3f468
record_format	dspace
spelling	oai:doaj.org-article:2fc9640b12e04f708de14928f2e3f4682021-12-02T19:02:07ZThe status of drug wastage in the pediatric emergency department of a tertiary hospital2231-07702249-446410.4103/ajm.ajm_58_19https://doaj.org/article/2fc9640b12e04f708de14928f2e3f4682020-01-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.4103/ajm.ajm_58_19https://doaj.org/toc/2231-0770https://doaj.org/toc/2249-4464Background: The aim of this study was to evaluate surplus drugs left over from medications used via the intravenous and intramuscular routes in a pediatric emergency unit of a tertiary hospital in Turkey and to determine the financial burden imposed by drug wastage. Materials and Methods: The study was planned prospectively on patients presenting to the pediatric emergency department of a tertiary university hospital between January 1 and April 30, 2017, on weekdays and between 08:00 and 16:00, for any reason, and receiving intravenous and/or intramuscular drug administration resulting in drug wastage after treatment. Results: The number of patients enrolled in the clinical trial was 1620 (35.9%). Twenty-one different medications were administered via the intravenous or intramuscular (IM) routes during the study. The proportion of total medication wastage at the end of trial was estimated to be 0.425. The drug with the highest proportion of mean wastage to drug form was paracetamol (1000mg vial) at 0.79. The total cost of the drugs used for the patients in the study was US$580.98, and the overall burden of drug wastage was US$288.09. The three medications involving the highest wastage costs were methylprednisolone, ondansetron, and dexamethasone. The total wastage cost/total drug cost ratio was 0.495. Conclusion: If commercial drugs with intravenous and IM formulations are used by the pediatric age group, then dosage formulations appropriate for pediatric age group use also need to be produced. The development by manufacturers of ampoules and similar products suitable for multiple use will also reduce drug wastage. Reducing levels of drug wastage will inevitably reduce the drug expenditure.Ibrahim Hakan BucakHabip AlmisCagla Nur DoganMehmet TurgutThieme Medical and Scientific Publishers Pvt. Ltd.articlecostdrugformulationspediatric emergency departmentwastageMedicineRENAvicenna Journal of Medicine, Vol 10, Iss 01, Pp 10-14 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	cost drug formulations pediatric emergency department wastage Medicine R
spellingShingle	cost drug formulations pediatric emergency department wastage Medicine R Ibrahim Hakan Bucak Habip Almis Cagla Nur Dogan Mehmet Turgut The status of drug wastage in the pediatric emergency department of a tertiary hospital
description	Background: The aim of this study was to evaluate surplus drugs left over from medications used via the intravenous and intramuscular routes in a pediatric emergency unit of a tertiary hospital in Turkey and to determine the financial burden imposed by drug wastage. Materials and Methods: The study was planned prospectively on patients presenting to the pediatric emergency department of a tertiary university hospital between January 1 and April 30, 2017, on weekdays and between 08:00 and 16:00, for any reason, and receiving intravenous and/or intramuscular drug administration resulting in drug wastage after treatment. Results: The number of patients enrolled in the clinical trial was 1620 (35.9%). Twenty-one different medications were administered via the intravenous or intramuscular (IM) routes during the study. The proportion of total medication wastage at the end of trial was estimated to be 0.425. The drug with the highest proportion of mean wastage to drug form was paracetamol (1000mg vial) at 0.79. The total cost of the drugs used for the patients in the study was US$580.98, and the overall burden of drug wastage was US$288.09. The three medications involving the highest wastage costs were methylprednisolone, ondansetron, and dexamethasone. The total wastage cost/total drug cost ratio was 0.495. Conclusion: If commercial drugs with intravenous and IM formulations are used by the pediatric age group, then dosage formulations appropriate for pediatric age group use also need to be produced. The development by manufacturers of ampoules and similar products suitable for multiple use will also reduce drug wastage. Reducing levels of drug wastage will inevitably reduce the drug expenditure.
format	article
author	Ibrahim Hakan Bucak Habip Almis Cagla Nur Dogan Mehmet Turgut
author_facet	Ibrahim Hakan Bucak Habip Almis Cagla Nur Dogan Mehmet Turgut
author_sort	Ibrahim Hakan Bucak
title	The status of drug wastage in the pediatric emergency department of a tertiary hospital
title_short	The status of drug wastage in the pediatric emergency department of a tertiary hospital
title_full	The status of drug wastage in the pediatric emergency department of a tertiary hospital
title_fullStr	The status of drug wastage in the pediatric emergency department of a tertiary hospital
title_full_unstemmed	The status of drug wastage in the pediatric emergency department of a tertiary hospital
title_sort	status of drug wastage in the pediatric emergency department of a tertiary hospital
publisher	Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate	2020
url	https://doaj.org/article/2fc9640b12e04f708de14928f2e3f468
work_keys_str_mv	AT ibrahimhakanbucak thestatusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT habipalmis thestatusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT caglanurdogan thestatusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT mehmetturgut thestatusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT ibrahimhakanbucak statusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT habipalmis statusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT caglanurdogan statusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital AT mehmetturgut statusofdrugwastageinthepediatricemergencydepartmentofatertiaryhospital
_version_	1718377256619868160

The status of drug wastage in the pediatric emergency department of a tertiary hospital

Ejemplares similares